These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2048 related items for PubMed ID: 17240129

  • 1. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 2. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 3. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
    Lin SY, Hsu CH, Sheu MT.
    J Pharm Biomed Anal; 2010 Nov 02; 53(3):799-803. PubMed ID: 20619996
    [Abstract] [Full Text] [Related]

  • 4. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubert RH, Hwang SJ.
    Eur J Pharm Biopharm; 2008 Jun 02; 69(2):454-65. PubMed ID: 18359211
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
    Yap KL, Liu X, Thenmozhiyal JC, Ho PC.
    Eur J Pharm Sci; 2005 May 02; 25(1):49-56. PubMed ID: 15854800
    [Abstract] [Full Text] [Related]

  • 6. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL, Pore YV, Kuchekar BS, Late SG.
    Pharmazie; 2008 Apr 02; 63(4):282-5. PubMed ID: 18468387
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
    Fathy M, Sheha M.
    Pharmazie; 2000 Jul 02; 55(7):513-7. PubMed ID: 10944779
    [Abstract] [Full Text] [Related]

  • 8. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J, Qiu L, Gao J, Jin Y.
    Int J Pharm; 2006 Apr 07; 312(1-2):137-43. PubMed ID: 16459034
    [Abstract] [Full Text] [Related]

  • 9. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO, Omoruyi SI, Oladimeji FA.
    Pharmazie; 2007 Nov 07; 62(11):858-63. PubMed ID: 18065103
    [Abstract] [Full Text] [Related]

  • 10. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
    Wang L, Jiang X, Xu W, Li C.
    Int J Pharm; 2007 Aug 16; 341(1-2):58-67. PubMed ID: 17482783
    [Abstract] [Full Text] [Related]

  • 11. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
    Garnero C, Zoppi A, Genovese D, Longhi M.
    Carbohydr Res; 2010 Nov 22; 345(17):2550-6. PubMed ID: 20933225
    [Abstract] [Full Text] [Related]

  • 12. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J, Dhiman N, Parmar VK, Sardana S, Bharatam PV, Aneja R, Chandra R, Katyal A.
    Cancer Chemother Pharmacol; 2010 Feb 22; 65(3):537-48. PubMed ID: 19597818
    [Abstract] [Full Text] [Related]

  • 13. Investigation of a fenofibrate-hydroxypropyl-beta-cyclodextrin system prepared by a co-grinding method.
    Gu FG, Wang Y, Meng GD, Han HB, Wu CZ.
    Pharmazie; 2012 Feb 22; 67(2):143-6. PubMed ID: 22512084
    [Abstract] [Full Text] [Related]

  • 14. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS, Han JY, Song TW, Sung JH, Kwon OS, Song S, Chung YB.
    Int J Pharm; 2006 Jun 19; 316(1-2):29-36. PubMed ID: 16574357
    [Abstract] [Full Text] [Related]

  • 15. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ, Kim MS, Lee S, Kim JS, Woo JS, Park JS, Hwang SJ.
    Int J Pharm; 2007 Jan 10; 328(2):152-60. PubMed ID: 16959448
    [Abstract] [Full Text] [Related]

  • 16. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L, Zhang H, Song W, Gu D, Hu Q.
    Carbohydr Polym; 2012 Nov 06; 90(4):1719-24. PubMed ID: 22944438
    [Abstract] [Full Text] [Related]

  • 17. Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
    Garnero C, Aiassa V, Longhi M.
    J Pharm Biomed Anal; 2012 Apr 07; 63():74-9. PubMed ID: 22361661
    [Abstract] [Full Text] [Related]

  • 18. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N, Ordu S.
    Drug Dev Ind Pharm; 1998 Jan 07; 24(1):19-25. PubMed ID: 15605593
    [Abstract] [Full Text] [Related]

  • 19. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R, Madan J, Kaushik D, Sardana S, Pandey RS, Sharma R.
    Pharm Dev Technol; 2013 Jan 07; 18(2):313-22. PubMed ID: 21699389
    [Abstract] [Full Text] [Related]

  • 20. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
    de Araujo DR, Tsuneda SS, Cereda CM, Del G F Carvalho F, Preté PS, Fernandes SA, Yokaichiya F, Franco MK, Mazzaro I, Fraceto LF, de F A Braga A, de Paula E.
    Eur J Pharm Sci; 2008 Jan 07; 33(1):60-71. PubMed ID: 18036789
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 103.